In patients with obesity, insulin resistance can be triggered by WAT inflammation (31), as WAT inflammation leads to the release of pro-inflammatory cytokines, such as TNFα, IL-1β, IL-6, that inhibit insulin signaling and impaired glucose uptake (32). The gene discussed is INS; the disease is obesity disorder.